Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity
about
The Gut Microbiota in Immune-Mediated Inflammatory DiseasesCellular and Molecular Connections between Autophagy and InflammationGenetic Diversity and Virulence Determinants of Escherichia coli Strains Isolated from Patients with Crohn's Disease in Spain and Chile.The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensMicrobial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum.Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period.The dual role of Escherichia coli in the course of ulcerative colitis.The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.Genetic Analysis and Detection of fliC H1 and fliC H12 Genes Coding for Serologically Closely Related Flagellar Antigens in Human and Animal Pathogenic Escherichia coli.Impact of Cranberries on Gut Microbiota and Cardiometabolic Health: Proceedings of the Cranberry Health Research Conference 2015.Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.Genome analysis of E. coli isolated from Crohn's disease patients.Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract InfectionsInfluence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients.Gut Microbiota Perturbations in Reactive Arthritis and Post-Infectious Spondyloarthritis.In vitro enteroid-derived three-dimensional tissue model of human small intestinal epithelium with innate immune responses.The effects of mucosal media on some pathogenic traits of Crohn's disease-associated Escherichia coli LF82.Comparative genomics reveals new single-nucleotide polymorphisms that can assist in identification of adherent-invasive Escherichia coli.NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.The Presence of Genotoxic and/or Pro-inflammatory Bacterial Genes in Gut Metagenomic Databases and Their Possible Link With Inflammatory Bowel Diseases.High carriage of adherent invasive E. coli in wildlife and healthy individuals.Glucocorticoids Impair Phagocytosis and Inflammatory Response Against Crohn's Disease-Associated Adherent-Invasive Escherichia coli.Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa.N-Acetyl-glucosamine influences the biofilm formation of Escherichia coli.Metagenomics-Based, Strain-Level Analysis of Escherichia coli From a Time-Series of Microbiome Samples From a Crohn's Disease PatientNod2 Deficiency in mice is Associated with Microbiota Variation Favouring the Expansion of mucosal CD4+ LAP+ Regulatory Cells
P2860
Q26741414-A879DF85-B26F-46FA-B074-E07DFB736014Q26798207-E4ED23CE-C650-4D18-B98A-BC3FD25834DEQ30352386-50FDB766-ADA1-4DBA-974A-239601230893Q33814705-961989B9-BDE0-49A7-8203-4ABA4CEF61EEQ35131669-A27D36AA-023D-479F-BC11-549D331A5B26Q35723593-982B638C-B694-4456-B1FF-1D594873010EQ36155351-59C33C16-D052-4BFD-9645-B6E759858D23Q36159700-73F4A655-CA1B-4467-A229-2AC78A23B79AQ36268539-497353E0-4DE8-468C-A4F6-E7DAF9C36266Q36579094-894CE7B0-A66A-4339-AB82-7036C139C29EQ37089830-5A679981-900F-4F25-8194-BE4E954E02E1Q37594944-70840D95-3DB4-483E-98CE-5264308EA855Q40116355-608689F0-8E82-40DF-AA5B-6C5A77547324Q40521114-2D1E3259-6737-4866-BA47-1F818EDE66D8Q46242554-B82FA26D-D240-401D-B759-79B77D8FEC51Q46252627-4BCF6C48-D639-4E57-8895-955ED323B1D4Q46274080-02D80403-318A-4210-A67A-1B8F673C1C0EQ47109988-61DB69A5-4409-4F22-8F58-B71F87E53C19Q47199332-2D4A4314-DED9-46C5-8BC3-736A1078BDD8Q49207699-E4B59361-2866-48EB-B412-5049D53195B4Q53434982-1F4BE44D-F324-4994-85C4-D5C6D2FE2885Q55014677-52649EC5-E537-46B2-A8C6-B187905B430CQ55305058-E0043D54-85A0-446C-9089-1E711556602EQ55354007-BE6EB023-919F-4534-BE65-939E9F814CC7Q55387301-935E2707-6AB5-451B-AEFD-3102806A022CQ55450202-6A179781-507A-49EA-A750-6E9FEBDDA55DQ58693878-3F774D9D-D206-494D-B5C9-BAAD6742B4BCQ58700504-1E6E9AFF-27BE-470E-B4D3-4346A42EB796
P2860
Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@ast
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@en
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@nl
type
label
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@ast
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@en
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@nl
prefLabel
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@ast
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@en
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@nl
P2860
P921
P356
P1476
Escherichia coli in chronic in ...... Escherichia coli pathogenicity
@en
P2093
Librado Jesus Garcia-Gil
P2860
P304
P356
10.4291/WJGP.V5.I3.213
P577
2014-08-01T00:00:00Z